Janouskova, Hana
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors. [electronic resource]
- Nature medicine 09 2017
- 1046-1054 p. digital
Publication Type: Journal Article
ISSN: 1546-170X
Standard No.: 10.1038/nm.4372 doi
Subjects--Topical Terms: Acetanilides--pharmacology Adenocarcinoma, Clear Cell--genetics Animals Apoptosis--drug effects Azepines--pharmacology Carcinoma, Endometrioid--genetics Carcinosarcoma--genetics Cell Cycle Proteins Cell Line, Tumor Cell Proliferation--drug effects Chromatography, Liquid Cullin Proteins--metabolism Drug Resistance, Neoplasm Endometrial Neoplasms--genetics Epigenesis, Genetic Female Heterocyclic Compounds, 3-Ring--pharmacology Humans Immunoblotting Immunohistochemistry Immunoprecipitation Male Mass Spectrometry Mice, Nude Molecular Targeted Therapy Mutation Neoplasm Transplantation Neoplasms, Cystic, Mucinous, and Serous--genetics Nuclear Proteins--antagonists & inhibitors Prostatic Neoplasms--genetics Protein Serine-Threonine Kinases--antagonists & inhibitors RNA-Binding Proteins--antagonists & inhibitors Repressor Proteins--genetics Reverse Transcriptase Polymerase Chain Reaction Transcription Factors--antagonists & inhibitors Triazoles--pharmacology Ubiquitination